|
Patients with migraine headaches of moderate or severe intensity may be eligible for trials with new migraine abortive medications. Participants will receive neurologic evaluation, medication, and follow-up assessments. Details are available by phone: (760) 631-3000.
You may be eligible to participate in an investigational research study.
- Must be 18 to 65 years old
- Must be diagnosed with migraine headaches
- Must have a stable medical condition
- Qualified participants receive: study-related medications, tests, and examinations
- Financial compensation is available
- For more information, please call 760.732.0557, ext 132.
Patients with frequent migraines may be eligible to participate in preventive studies. We are recruiting patients who have at least 4 migraines monthly for trials of various medications for prevention of migraine.
|